These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 9848716

  • 1. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis.
    Wenzel BE, Chow A, Baur R, Schleusener H, Wall JR.
    Thyroid; 1998 Nov; 8(11):1019-22. PubMed ID: 9848716
    [Abstract] [Full Text] [Related]

  • 2. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
    Inukai T, Takanashi K, Takebayashi K, Fujiwara Y, Tayama K, Takemura Y.
    Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
    [Abstract] [Full Text] [Related]

  • 3. Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.
    Romaldini JH, Werner MC, Rodrigues HF, Teixeira VL, Werner RS, Farah CS, Bromberg N.
    J Endocrinol Invest; 1986 Jun; 9(3):233-8. PubMed ID: 2428860
    [Abstract] [Full Text] [Related]

  • 4. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K, Berdowska A, Jochem J, Sitkiewicz A, Birkner E, Polaniak R, Jedrzejowska-Szypułka H, Korzonek-Szlacheta I.
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [Abstract] [Full Text] [Related]

  • 5. An elevation of stem cell factor in patients with hyperthyroid Graves' disease.
    Yamada T, Sato A, Aizawa T, Ootsuka H, Miyahara Y, Sakai H, Terao A, Onuma S, Ito Y, Kanamori A, Nakamura Y, Tejima E.
    Thyroid; 1998 Jun; 8(6):499-504. PubMed ID: 9669287
    [Abstract] [Full Text] [Related]

  • 6. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.
    Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, De Liperi A, Bartolozzi C, Pinchera A, Martino E.
    J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158
    [Abstract] [Full Text] [Related]

  • 7. Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
    Solerte SB, Precerutti S, Gazzaruso C, Locatelli E, Zamboni M, Schifino N, Bonacasa R, Rondanelli M, Taccani D, Ferrari E, Fioravanti M.
    Eur J Endocrinol; 2005 May; 152(5):703-12. PubMed ID: 15879355
    [Abstract] [Full Text] [Related]

  • 8. Serial analysis of the effects of methimazole or radical therapy on circulating CD16/56 subpopulations in Graves' disease.
    Rojano J, Sasián S, Gavilán I, Aguilar M, Escobar L, Girón JA.
    Eur J Endocrinol; 1998 Sep; 139(3):314-6. PubMed ID: 9758442
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
    Chan JY, Walfish PG.
    Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
    Watanabe M, Amino N, Hochito K, Watanabe K, Kuma K, Iwatani Y.
    Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
    [Abstract] [Full Text] [Related]

  • 17. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
    Chan JY, Walfish PG.
    J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical studies on autoimmune mechanisms of the thyroid Part II. Leucocyte migration inhibiton studies in Hashimoto's thyroiditis and in Graves' disease (author's transol)].
    Ikekubo K.
    Nihon Naibunpi Gakkai Zasshi; 1975 Oct 20; 51(10):840-55. PubMed ID: 1243915
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.